Telomir Pharmaceuticals (TELO) Stock Chart & Stock Price History $1.96 -0.04 (-2.00%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.96 0.00 (-0.20%) As of 06/13/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Telomir Pharmaceuticals Stock Price Performance The Telomir Pharmaceuticals (TELO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.36%, with a year-to-date return of -52.43%. In the past month, the stock has decreased 21.60%, reflecting recent market activity. As of the latest close, Telomir Pharmaceuticals traded at $1.96 with a market cap of $58.34 million and volume of 322,674 shares. Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.51%1 Month Performance-21.60%3 Month Performance-57.21%Year-To-Date Performance-52.43%1 Year Performance-64.36% TELO Stock Chart for Monday, June, 16, 2025 TELO Chart by TradingView Telomir Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$2.00$1.96-2.00%$2.05$1.85322,674 shs$58.34 million06/12/2025$1.97$2.00+1.52%$2.00$1.91190,160 shs$59.53 million06/11/2025$2.05$1.97-3.90%$2.10$1.95304,167 shs$58.63 million06/10/2025$1.98$2.05+3.54%$2.09$1.96186,173 shs$61.01 million06/09/2025$2.15$1.98-7.91%$2.49$1.95444,146 shs$58.93 million06/06/2025$2.01$2.15+6.97%$2.15$2.01181,969 shs$63.99 million06/05/2025$2.11$2.01-4.74%$2.18$1.871.56 million shs$59.82 million06/04/2025$2.04$2.11+3.43%$2.17$2.00210,963 shs$62.80 million06/03/2025$2.10$2.04-2.86%$2.15$2.01126,617 shs$60.72 million06/02/2025$1.95$2.10+7.69%$2.10$1.95176,530 shs$62.50 million Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$2.10$1.95-7.14%$2.09$1.88141,543 shs$58.04 million05/29/2025$2.07$2.10+1.45%$2.19$2.03205,839 shs$62.50 million05/28/2025$2.10$2.07-1.43%$2.10$2.0181,319 shs$61.61 million05/27/2025$2.10$2.10$2.18$2.08112,252 shs$62.50 million05/26/2025$2.10$2.10$2.14$2.04109,322 shs$62.50 million05/23/2025$2.20$2.10-4.55%$2.14$2.04109,322 shs$62.50 million05/22/2025$2.13$2.20+3.29%$2.20$1.98137,169 shs$65.48 million05/21/2025$2.29$2.13-6.99%$2.35$2.11113,651 shs$63.40 million05/20/2025$2.54$2.29-9.84%$2.60$2.25180,732 shs$68.16 million05/19/2025$2.50$2.54+1.60%$2.59$2.3597,551 shs$75.60 million05/16/2025$2.36$2.50+5.93%$2.50$2.27103,624 shs$74.41 million05/15/2025$2.66$2.36-11.28%$2.75$2.29349,560 shs$70.24 million Related Companies Cara Therapeutics Stock Price Chart Esperion Therapeutics Stock Price Chart Y-mAbs Therapeutics Stock Price Chart MediWound Stock Price Chart Acelyrin Stock Price Chart Tevogen Bio Stock Price Chart Design Therapeutics Stock Price Chart biote Stock Price Chart Nanobiotix Stock Price Chart scPharmaceuticals Stock Price Chart Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TELO) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.